Build Your Comparison

Side-by-side financial analysis
VABK logo
VABK
CARE logo
CARE
KO logo
KO
Try popular comparisons:

Stock Comparison

VABK vs CARE vs KO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
VABK
Virginia National Bankshares Corporation

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$244M
5Y Perf.+78.2%
CARE
Carter Bankshares, Inc.

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$662M
5Y Perf.+270.2%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$355.61B
5Y Perf.+84.9%

VABK vs CARE vs KO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
VABK logoVABK
CARE logoCARE
KO logoKO
IndustryBanks - RegionalBanks - RegionalBeverages - Non-Alcoholic
Market Cap$244M$662M$355.61B
Revenue (TTM)$83M$252M$49.28B
Net Income (TTM)$19M$31M$13.70B
Gross Margin69.0%61.2%61.7%
Operating Margin28.9%15.9%29.3%
Forward P/E12.7x5.5x25.3x
Total Debt$30M$179M$45.49B
Cash & Equiv.$6M$105M$10.27B

VABK vs CARE vs KOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

VABK
CARE
KO
StockJun 20Jun 26Return
Virginia National B… (VABK)100178.2+78.2%
Carter Bankshares, … (CARE)100370.2+270.2%
The Coca-Cola Compa… (KO)100184.9+84.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: VABK vs CARE vs KO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: VABK leads in 3 of 7 categories, making it the strongest pick for valuation and capital efficiency and capital preservation and lower volatility. Carter Bankshares, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇VABK emerged as the overall leader. Track its performance:
VABK
Virginia National Bankshares Corporation
The Banking Pick

VABK has the current edge in this matchup, primarily because of its strength in income & stability and sleep-well-at-night.

  • Dividend streak 1 yrs, beta 0.48, yield 3.1%
  • Lower volatility, beta 0.48, Low D/E 16.2%, current ratio 3.53x
  • Beta 0.48, yield 3.1%, current ratio 3.53x
Best for: income & stability and sleep-well-at-night
CARE
Carter Bankshares, Inc.
The Banking Pick

CARE is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 6.2%, EPS growth 32.1%
  • 141.7% 10Y total return vs VABK's 146.5%
  • 6.2% NII/revenue growth vs VABK's 0.9%
Best for: growth exposure and long-term compounding
KO
The Coca-Cola Company
The Value Pick

KO is the clearest fit if your priority is valuation efficiency.

  • PEG 2.26 vs VABK's 3.36
  • 27.8% margin vs CARE's 12.5%
  • 13.1% ROA vs CARE's 0.7%, ROIC 15.8% vs 5.7%
Best for: valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthCARE logoCARE6.2% NII/revenue growth vs VABK's 0.9%
ValueVABK logoVABKLower P/E (12.7x vs 25.3x)
Quality / MarginsKO logoKO27.8% margin vs CARE's 12.5%
Stability / SafetyVABK logoVABKBeta 0.48 vs CARE's 0.58, lower leverage
DividendsVABK logoVABK3.1% yield, 1-year raise streak, vs KO's 2.5%, (1 stock pays no dividend)
Momentum (1Y)CARE logoCARE+79.6% vs KO's +17.2%
Efficiency (ROA)KO logoKO13.1% ROA vs CARE's 0.7%, ROIC 15.8% vs 5.7%

VABK vs CARE vs KO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

VABKVirginia National Bankshares Corporation

Segment breakdown not available.

CARECarter Bankshares, Inc.
FY 2025
Bank Owned Life Insurance Income
74.0%$2M
Other Revenue
26.0%$532,000
KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B

VABK vs CARE vs KO — Financial Metrics

Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLKOLAGGINGCARE

Income & Cash Flow (Last 12 Months)

KO leads this category, winning 3 of 5 comparable metrics.

KO is the larger business by revenue, generating $49.3B annually — 591.4x VABK's $83M. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to CARE's 12.5%.

MetricVABK logoVABKVirginia National…CARE logoCARECarter Bankshares…KO logoKOThe Coca-Cola Com…
RevenueTrailing 12 months$83M$252M$49.3B
EBITDAEarnings before interest/tax$26M$46M$15.5B
Net IncomeAfter-tax profit$19M$31M$13.7B
Free Cash FlowCash after capex$21M$30M$12.6B
Gross MarginGross profit ÷ Revenue+69.0%+61.2%+61.7%
Operating MarginEBIT ÷ Revenue+28.9%+15.9%+29.3%
Net MarginNet income ÷ Revenue+23.1%+12.5%+27.8%
FCF MarginFCF ÷ Revenue+24.9%+11.9%+25.5%
Rev. Growth (YoY)Latest quarter vs prior year+12.1%
EPS Growth (YoY)Latest quarter vs prior year+31.0%+8.3%+18.2%
KO leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

VABK leads this category, winning 4 of 7 comparable metrics.

At 12.7x trailing earnings, VABK trades at a 53% valuation discount to KO's 27.2x P/E. Adjusting for growth (PEG ratio), KO offers better value at 2.43x vs VABK's 3.36x — a lower PEG means you pay less per unit of expected earnings growth.

MetricVABK logoVABKVirginia National…CARE logoCARECarter Bankshares…KO logoKOThe Coca-Cola Com…
Market CapShares × price$244M$662M$355.6B
Enterprise ValueMkt cap + debt − cash$268M$735M$390.8B
Trailing P/EPrice ÷ TTM EPS12.68x21.34x27.18x
Forward P/EPrice ÷ next-FY EPS est.5.47x25.27x
PEG RatioP/E ÷ EPS growth rate3.36x2.43x
EV / EBITDAEnterprise value multiple11.13x18.38x26.39x
Price / SalesMarket cap ÷ Revenue2.93x2.60x7.42x
Price / BookPrice ÷ Book value/share1.32x1.60x10.40x
Price / FCFMarket cap ÷ FCF11.76x20.81x67.15x
VABK leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

KO leads this category, winning 5 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $8 for CARE. VABK carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to KO's 1.33x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs VABK's 6/9, reflecting strong financial health.

MetricVABK logoVABKVirginia National…CARE logoCARECarter Bankshares…KO logoKOThe Coca-Cola Com…
ROE (TTM)Return on equity+11.0%+7.6%+41.1%
ROA (TTM)Return on assets+1.2%+0.7%+13.1%
ROICReturn on invested capital+9.0%+5.7%+15.8%
ROCEReturn on capital employed+2.6%+1.5%+17.3%
Piotroski ScoreFundamental quality 0–9687
Debt / EquityFinancial leverage0.16x0.43x1.33x
Net DebtTotal debt minus cash$24M$73M$35.2B
Cash & Equiv.Liquid assets$6M$105M$10.3B
Total DebtShort + long-term debt$30M$179M$45.5B
Interest CoverageEBIT ÷ Interest expense0.94x0.39x10.70x
KO leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CARE leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in CARE five years ago would be worth $20,802 today (with dividends reinvested), compared to $15,088 for VABK. Over the past 12 months, CARE leads with a +79.6% total return vs KO's +17.2%. The 3-year compound annual growth rate (CAGR) favors CARE at 24.7% vs KO's 13.7% — a key indicator of consistent wealth creation.

MetricVABK logoVABKVirginia National…CARE logoCARECarter Bankshares…KO logoKOThe Coca-Cola Com…
YTD ReturnYear-to-date+15.2%+54.3%+20.3%
1-Year ReturnPast 12 months+24.1%+79.6%+17.2%
3-Year ReturnCumulative with dividends+61.9%+93.9%+47.0%
5-Year ReturnCumulative with dividends+50.9%+108.0%+65.6%
10-Year ReturnCumulative with dividends+146.5%+141.7%+121.1%
CAGR (3Y)Annualised 3-year return+17.4%+24.7%+13.7%
CARE leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CARE and KO each lead in 1 of 2 comparable metrics.

KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than CARE's 0.58 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CARE currently trades 99.6% from its 52-week high vs VABK's 92.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricVABK logoVABKVirginia National…CARE logoCARECarter Bankshares…KO logoKOThe Coca-Cola Com…
Beta (5Y)Sensitivity to S&P 5000.48x0.58x-0.20x
52-Week HighHighest price in past year$48.58$29.99$84.04
52-Week LowLowest price in past year$36.48$16.14$65.35
% of 52W HighCurrent price vs 52-week peak+92.6%+99.6%+98.3%
RSI (14)Momentum oscillator 0–10063.072.860.6
Avg Volume (50D)Average daily shares traded6K316K12.7M
Evenly matched — CARE and KO each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — VABK and KO each lead in 1 of 2 comparable metrics.

Analyst consensus: CARE as "Hold", KO as "Buy". Consensus price targets imply 4.2% upside for KO (target: $86) vs -4.6% for CARE (target: $29). For income investors, VABK offers the higher dividend yield at 3.12% vs KO's 2.46%.

MetricVABK logoVABKVirginia National…CARE logoCARECarter Bankshares…KO logoKOThe Coca-Cola Com…
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$28.50$86.13
# AnalystsCovering analysts548
Dividend YieldAnnual dividend ÷ price+3.1%+2.5%
Dividend StreakConsecutive years of raises1056
Dividend / ShareAnnual DPS$1.40$2.04
Buyback YieldShare repurchases ÷ mkt cap0.0%+3.0%+0.2%
Evenly matched — VABK and KO each lead in 1 of 2 comparable metrics.
Key Takeaway

KO leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). VABK leads in 1 (Valuation Metrics). 2 tied.

Best OverallThe Coca-Cola Company (KO)Leads 2 of 6 categories
Loading custom metrics...

VABK vs CARE vs KO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is VABK or CARE or KO a better buy right now?

For growth investors, Carter Bankshares, Inc.

(CARE) is the stronger pick with 6. 2% revenue growth year-over-year, versus 0. 9% for Virginia National Bankshares Corporation (VABK). Virginia National Bankshares Corporation (VABK) offers the better valuation at 12. 7x trailing P/E, making it the more compelling value choice. Analysts rate The Coca-Cola Company (KO) a "Buy" — based on 48 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — VABK or CARE or KO?

On trailing P/E, Virginia National Bankshares Corporation (VABK) is the cheapest at 12.

7x versus The Coca-Cola Company at 27. 2x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — VABK or CARE or KO?

Over the past 5 years, Carter Bankshares, Inc.

(CARE) delivered a total return of +108. 0%, compared to +50. 9% for Virginia National Bankshares Corporation (VABK). Over 10 years, the gap is even starker: VABK returned +146. 5% versus KO's +121. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — VABK or CARE or KO?

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

20β versus Carter Bankshares, Inc. 's 0. 58β — meaning CARE is approximately -387% more volatile than KO relative to the S&P 500. On balance sheet safety, Virginia National Bankshares Corporation (VABK) carries a lower debt/equity ratio of 16% versus 133% for The Coca-Cola Company — giving it more financial flexibility in a downturn.

05

Which is growing faster — VABK or CARE or KO?

By revenue growth (latest reported year), Carter Bankshares, Inc.

(CARE) is pulling ahead at 6. 2% versus 0. 9% for Virginia National Bankshares Corporation (VABK). On earnings-per-share growth, the picture is similar: Carter Bankshares, Inc. grew EPS 32. 1% year-over-year, compared to 12. 7% for Virginia National Bankshares Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — VABK or CARE or KO?

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus 12. 3% for Carter Bankshares, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VABK leads at 28. 9% versus 15. 7% for CARE. At the gross margin level — before operating expenses — VABK leads at 69. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is VABK or CARE or KO more undervalued right now?

On forward earnings alone, Carter Bankshares, Inc.

(CARE) trades at 5. 5x forward P/E versus 25. 3x for The Coca-Cola Company — 19. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KO: 4. 2% to $86. 13.

08

Which pays a better dividend — VABK or CARE or KO?

In this comparison, VABK (3.

1% yield), KO (2. 5% yield) pay a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.

09

Is VABK or CARE or KO better for a retirement portfolio?

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

20), 2. 5% yield, +121. 1% 10Y return). Both have compounded well over 10 years (KO: +121. 1%, CARE: +141. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between VABK and CARE and KO?

These companies operate in different sectors (VABK (Financial Services) and CARE (Financial Services) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: VABK is a small-cap deep-value stock; CARE is a small-cap quality compounder stock; KO is a large-cap quality compounder stock. VABK, KO pay a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.